Majority of Patients Treated with Lebrikizumab Achieved Skin Clearance in Lilly's Pivotal Phase 3 Atopic Dermatitis Studies
Posted:
Millions of people with atopic dermatitis cope with both seen and unseen burdens of the disease. Discover more about important new clinical trial results and how Lilly is helping to improve care and understanding of this disease here.
WhatsApp has introduced private chats with its AI chatbot which not even the tech company will be able to read in a new "incognito" mode.
The technology behind WhatsApp's incognito mode is not the same as the end-to-end encryption the platform uses…
The stresses and strains of caring for someone for 50 hours or more a week leads to “accelerated cognitive decline” in middle-aged and older people, research shows. By 2040, around 20% of adults in England will be living with major illnesses.…
Attendees
Sponsors and Exhibitors
Contact us